Over three million on new HIV drug dolutegravir, but co... :

switching from old second-line regimens to dolutegravir-based regimensConcerns around drug to drug interactions with dolutegravir

Related Keywords

South Africa , Brazil , Botswana , Brazilian , Francois Venter , Josephine Otchere Darko , Foster Mohale , National Department Of Health , National Department Of Health Knowledge Hub , Clinicians Society Sahcs , World Health Organization , University Of The Witwatersrand , National Department , Professor Francois Venter , Southern African , Knowledge Hub ,